Dating back to the first human-aided cross-pollination, biotechnology has evolved a long way. In the recent years, biotechnology has made huge leaps and bounds to become more sophisticated, making headways towards more expansive applicability. What was found only in the pages of science fiction books a few years back is true today. For instance, the world remained a spellbound witness as FDA approved Luxturna, a gene therapy capable of reversing a rare type of childhood blindness.

Aiming at the penetration of industrial biotechnology across industries, the demand for DNA sequencing, fermentation and recombinant technology is steadily increasing. Biomolecular engineers are paying special focus on the human microbiome; the synergistic relationships among microbes are being leveraged in order to accelerate the processing of chemicals in a mild environment. In addition, researchers are turning their interests toward bionic plants and natural plant biosynthesis from biofuels, with an objective to develop anti-cancer vaccines and proteins.

That’s not all. Tissue engineering has opened ways to clinical biofabrication; scientists can now fabricate biosynthetic organs and implant it into patients. Moreover, modern biosensors can monitor infections in real-time, releasing antiseptics as and when required. All the advancements are aimed at a single objective—to drive immunocompatibility, fabrication reproducibility and not to mention, cost-effectiveness.

While cutting-edge technology ensures a long-term growth for the biotech space, it is an uphill task for customers to decide on one from the wide assemblage of solutions. To make this task easier, we have assessed the top companies that solve biotech challenges by implementing the current technological trends in the space. A distinguished panel comprising CEOs, CIOs, VCs, Analysts and the editorial board of StartupCity has selected a list of biotech startups.

We present to you StartupCity’s “15 Most Promising Biotech Startups - 2018.”